Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Malignant Lymphoma

Free Subscription 24.06.2019 1 Am J Hematol 1 Am J Surg Pathol 1 Blood 2 BMC Cancer 4 Br J Haematol 3 Eur J Haematol 3 Haematologica 6 Leuk Lymphoma

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Hematol

1. KHARFAN-DABAJA MA, Jain MD, Aulakh S, Ayala E, et al
   Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells.
   Am J Hematol. 2019 Jun 18. doi: 10.1002/ajh.25560.
   PubMed     Text format    
   
   

   
   Am J Surg Pathol

2. KIM DH, Medeiros LJ, Aung PP, Young KH, et al
   Mantle Cell Lymphoma Involving Skin: A Clinicopathologic Study of 37 Cases.
   Am J Surg Pathol. 2019 Jun 18. doi: 10.1097/PAS.0000000000001312.
   PubMed     Text format     Abstract available
   
   

   
   Blood

3. CHAN AC, Vali Betts E
   Mantle cell lymphoma with unusual Burkitt-like morphologic features.
   Blood. 2019;133:2729.
   PubMed     Text format    
   
   

   
   BMC Cancer

4. BAN Y, Jing Z, Zou J
   Multiple secondary cauda equina non-Hodgkin's lymphoma: a case report and literature review.
   BMC Cancer. 2019;19:594.
   PubMed     Text format     Abstract available
   
   
5. GROVER NS, Savoldo B
   Challenges of driving CD30-directed CAR-T cells to the clinic.
   BMC Cancer. 2019;19:203.
   PubMed     Text format     Abstract available
   
   

   
   Br J Haematol

6. KATO H, Kato K, Kim SW, Fukuda T, et al
   Clinical outcomes of hepatitis B or C virus infections in patients with malignant lymphoma receiving autologous stem cell transplantation: on behalf of the Adult Lymphoma Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHC
   Br J Haematol. 2019 Jun 17. doi: 10.1111/bjh.16050.
   PubMed     Text format    
   
   
7. ONG DM, Ashby M, Grigg A, Gard G, et al
   Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations.
   Br J Haematol. 2019 Jun 17. doi: 10.1111/bjh.16049.
   PubMed     Text format     Abstract available
   
   
8. ROY SF, Ghazawi FM, Powell J, Kokta V, et al
   EBV-associated hydroa vacciniforme-like T-cell lymphoma.
   Br J Haematol. 2019 Jun 19. doi: 10.1111/bjh.16065.
   PubMed     Text format    
   
   
9. DJEBBARI F, Browning JA, Stanton L, Booth S, et al
   Efficacy of R-GCVP in patients with late relapse of diffuse large B-cell lymphoma.
   Br J Haematol. 2019 Jun 20. doi: 10.1111/bjh.16071.
   PubMed     Text format    
   
   

   
   Eur J Haematol

10. HEGER JM, Eichenauer DA, Kasper P, Boll B, et al
    Fatal disseminated enterovirus infection in a patient with follicular lymphoma undergoing obinutuzumab maintenance therapy.
    Eur J Haematol. 2019 Jun 18. doi: 10.1111/ejh.13278.
    PubMed     Text format     Abstract available
    
    
11. WANG L, Peng S, Sun W, Liu X, et al
    Bevacizumab synergizes with the BCL 2 inhibitor venetoclax to effectively treat B-cell non-Hodgkin's lymphoma.
    Eur J Haematol. 2019 Jun 18. doi: 10.1111/ejh.13279.
    PubMed     Text format     Abstract available
    
    
12. KEANE C, Tobin J, Gunawardana J, Francis S, et al
    The tumor microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV positive Diffuse Large B Cell Lymphoma.
    Eur J Haematol. 2019 Jun 18. doi: 10.1111/ejh.13274.
    PubMed     Text format     Abstract available
    
    

    
    Haematologica

13. MARTIN-CORTAZAR C, Chiodo Y, Jimenez-P R, Bernabe M, et al
    CDCA7 finely tunes cytoskeleton dynamics to promote lymphoma migration and invasion.
    Haematologica. 2019 Jun 20. pii: haematol.2018.215459.
    PubMed     Text format     Abstract available
    
    
14. NOWAKOWSKI GS, Chiappella A, Witzig TE, Scott DW, et al
    Variable global distribution of cell-of-origin from the ROBUST phase 3 study in diffuse large B-cell lymphoma.
    Haematologica. 2019 Jun 20. pii: haematol.2019.220475.
    PubMed     Text format    
    
    
15. HU T, Chong Y, Lu S, McGuinness M, et al
    RAC1/2 activation promotes FGFR1 driven leukemogenesis in stem cell leukemia/lymphoma syndrome.
    Haematologica. 2019 Jun 20. pii: haematol.2018.208058.
    PubMed     Text format    
    
    

    
    Leuk Lymphoma

16. TOBIASSON M, Pandzic T, Cavelier L, Sander B, et al
    Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in TET2, DNMT3 and CUX1 - azacitidine induces only lymphoma remission.
    Leuk Lymphoma. 2019 Jun 17:1-4. doi: 10.1080/10428194.2019.1627541.
    PubMed     Text format    
    
    
17. ACUNA-VILLAORDUNA A, Gonzalez-Lugo J, Ye BH, Adrianzen Herrera DA, et al
    High prevalence of pulmonary findings in computed tomographies of HTLV-1-infected patients with and without adult-T cell leukemia/lymphoma - implications for staging.
    Leuk Lymphoma. 2019 Jun 17:1-5. doi: 10.1080/10428194.2019.1627543.
    PubMed     Text format     Abstract available
    
    
18. ZHONG C, Gragert L, Maiers M, Hill BT, et al
    The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population.
    Leuk Lymphoma. 2019 Jun 19:1-10. doi: 10.1080/10428194.2019.1617858.
    PubMed     Text format     Abstract available
    
    
19. PERSONETT HA, Barreto EF, McCullough KB, Dierkhising R, et al
    Impact of early rasburicase on incidence of clinical tumor lysis syndrome in lymphoma.
    Leuk Lymphoma. 2019 Jun 21:1-7. doi: 10.1080/10428194.2019.1574000.
    PubMed     Text format     Abstract available
    
    
20. BEHDAD A, Boddy CS, Fought AJ, Taxter T, et al
    Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status.
    Leuk Lymphoma. 2019 Jun 21:1-6. doi: 10.1080/10428194.2019.1622099.
    PubMed     Text format     Abstract available
    
    
21. MILJKOVIC MD, Roschewski M, Dunleavy K, Wilson WH, et al
    Hybrid dosing of the cyclin-dependent kinase (CDK) inhibitor flavopiridol in relapsed/refractory mantle cell lymphoma and diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2019 Jun 17:1-4. doi: 10.1080/10428194.2019.1627540.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: